MENU
NRIX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Nurix Therapeutics (NRIX) Ownership - Who owns Nurix Therapeutics?
Profile
Industry
N/A
Address
1700 Owens Street
Phone
+1 415 660-5320
Employees
284
Web
http://www.nurixtx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.28B
P/E Ratio
N/A
Total Cash
609.58M
Projected Growth
N/A
Total Debt
28.3M
Revenue
54.55M
Risk (Beta)
1.90
Dividend Yield
N/A
Total Cash/Share
8.03
Total Debt/Equity
N/A
Revenue/Share
0.81 USD as % of share price
Fundamentals
NRIX
Capitalization
1.28B
P/E Ratio
N/A
Risk (Beta)
1.90
Dividend Yield
N/A
Total Cash
610M
Total Cash/Share
8.03
Total Debt
28.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.81%
Revenue
54.5M
ROE
N/A
Book Value
527M
P/B Ratio
2.43
Cash Flow
N/A
Earnings
-2.88
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
76K
Current Ratio
6.46
Current Revenue Per Employee
46447.55
Dividends Per Share - Security
N/A
EBITDA
-196.6M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-37.77
Shares Held By Institutions
2.32B
Shares Outstanding - Current
75.9M
Total Liabilities
142M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-11.200
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company, which focuses on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1700 Owens Street
Phone
+1 415 660-5320
Employees
284
Web
http://www.nurixtx.com